Kaizen Biosciences Advances Pediatric Antibiotic With Promising Data and FDA Fast-Track Aspirations
PHILADELPHIA, PA — Kaizen Biosciences, Co., a Philadelphia-based biopharmaceutical firm, is making strides toward regulatory approval for its novel pediatric antibiotic formulation, following the acceptance of new research for presentation …
Kaizen Biosciences Advances Pediatric Antibiotic With Promising Data and FDA Fast-Track Aspirations Read More